The use of kDNA minicircle subclass relative abundance to differentiate between Leishmania (L.) infantum and Leishmania (L.) amazonensis

Background Leishmaniasis is a neglected disease caused by many Leishmania species, belonging to subgenera Leishmania (Leishmania) and Leishmania (Viannia). Several qPCR-based molecular diagnostic approaches have been reported for detection and quantification of Leishmania species. Many of these approaches use the kinetoplast DNA (kDNA) minicircles as the target sequence. These assays had potential cross-species amplification, due to sequence similarity between Leishmania species. Previous works demonstrated discrimination between L. (Leishmania) and L. (Viannia) by SYBR green-based qPCR assays designed on kDNA, followed by melting or high-resolution melt (HRM) analysis. Importantly, these approaches cannot fully distinguish L. (L.) infantum from L. (L.) amazonensis, which can coexist in the same geographical area. Methods DNA from 18 strains/isolates of L. (L.) infantum, L. (L.) amazonensis, L. (V.) braziliensis, L. (V.) panamensis, L. (V.) guyanensis, and 62 clinical samples from L. (L.) infantum-infected dogs were amplified by a previously developed qPCR (qPCR-ML) and subjected to HRM analysis; selected PCR products were sequenced using an ABI PRISM 310 Genetic Analyzer. Based on the obtained sequences, a new SYBR-green qPCR assay (qPCR-ama) intended to amplify a minicircle subclass more abundant in L. (L.) amazonensis was designed. Results The qPCR-ML followed by HRM analysis did not allow discrimination between L. (L.) amazonensis and L. (L.) infantum in 53.4% of cases. Hence, the novel SYBR green-based qPCR (qPCR-ama) has been tested. This assay achieved a detection limit of 0.1 pg of parasite DNA in samples spiked with host DNA and did not show cross amplification with Trypanosoma cruzi or host DNA. Although the qPCR-ama also amplified L. (L.) infantum strains, the Cq values were dramatically increased compared to qPCR-ML. Therefore, the combined analysis of Cq values from qPCR-ML and qPCR-ama allowed to distinguish L. (L.) infantum and L. (L.) amazonensis in 100% of tested samples. Conclusions A new and affordable SYBR-green qPCR-based approach to distinguish between L. (L.) infantum and L. (L.) amazonensis was developed exploiting the major abundance of a minicircle sequence rather than targeting a hypothetical species-specific sequence. The fast and accurate discrimination between these species can be useful to provide adequate prognosis and treatment. Electronic supplementary material The online version of this article (doi:10.1186/s13071-017-2181-x) contains supplementary material, which is available to authorized users.


Background
Leishmaniasis is a spectral neglected disease caused by many Leishmania species, primarily transmitted by phlebotomine sand flies [1]. Leishmaniasis is a public health problem in 98 countries, in both rural and urban areas. About 12 million people are currently affected by the disease; in particular, 0.2-0.4 million cases per year of visceral leishmaniasis (VL) and 0.7-1.2 million cases per year of cutaneous leishmaniasis (CL) have been estimated [2]. Leishmania parasites are classified in three different subgenera: Leishmania (Leishmania), Leishmania (Viannia) and Leishmania (Sauroleishmania). Parasites in the subgenera Leishmania and Viannia infect mammals, whereas the Sauroleishmania infect reptiles [3]. Over 30 Leishmania species have been identified, including many that are non-pathogenic or of minor medical importance. The Leishmania donovani complex belongs to the subgenus Leishmania (Leishmania), the etiological agent of VL and CL, and includes L. (L.) infantum and L. (L.) donovani. The species belonging to the subgenus Leishmania (Viannia) are etiological agents of CL and mucocutaneous leishmaniasis.
An accurate diagnostic method that allows the distinction between Leishmania species with overlapping geographical distributions is needed [4]. Since isoenzymatic characterization is laborious and time-expensive, various molecular approaches have been developed based on detection of different Leishmania target sequences [5,6]. In particular, the conserved region of Leishmania kinetoplast DNA (kDNA) minicircles has been used as a specific target for real-time PCR assays, able to distinguish Old World [7,8] and New World species [9]. The kDNA is situated at the base of the flagellum and contains thousands of minicircles and dozens of maxicircles concatenated in a giant network [10]. The high number of minicircles (10,000-26,000 copies/parasite) [11][12][13] make them an attractive target for Leishmania detection with high sensitivity [14]. However, the minicircle network is composed of different minicircle subclasses conserved in different Leishmania species [15,16]. Therefore, most of the available PCR or qPCR assays designed for a single species can potentially amplify more than one Leishmania species [13,14,17].
Previous works demonstrated the possibility to discriminate between L. (Leishmania) and L. (Viannia) by SYBR green-based qPCR assays designed on kDNA conserved sequences, followed by melting or highresolution melt (HRM) analysis [13,18]. These approaches did not efficiently distinguish L. (L.) infantum from L. (L.) amazonensis, which can coexist in the same geographic area. These species infect both humans and dogs [19], and their differentiation is critical for correct treatment. In fact, both species can present with cutaneous manifestations, but L. (L.) amazonensis can also cause diffuse disease that does not respond well to current treatments [5]. Moreover, the use of immunosuppressant may alter the clinical course of Leishmaniasis (e.g. viscerotropic strains can result in cutaneous lesions, and dermotropic strains can result in visceral disease). These issues are particularly important in South America, where both species are endemic, and deforestation and uncontrolled urbanisation are responsible for the growing incidence of leishmaniasis [20].
The aim of this work is to investigate the kDNA sequence variability among different Leishmania species and to exploit these differences to develop a qPCR-based analysis that differentiates L. (L.) infantum from L. (L.) amazonensis.

Leishmania strains, clinical samples and DNA extraction
The DNA from promastigotes of Leishmania spp. isolates listed in Table 1 was chelex-purified. Conjunctival swabs (CS) or buffy coat (BC) samples from 21 dogs diagnosed with leishmaniasis were provided by the veterinary clinic "Santa Teresa" (Fano, Italy). The DNA from CS and BC samples was extracted as previously described [21]. The L. amazonensis and L. (Viannia) spp. clinical isolates were provided by Instituto de Patología Experimental (IPE), Facultad de Ciencias de la Salud -Universidad Nacional de Salta-Argentina and typed at the species level at the Institute of Biomedicine and Molecular  Immunology, CNR (Palermo, Italy) [13]. The L. infantum clinical isolates have been characterised by multilocus enzyme electrophoresis (MLEE) at Istituto Superiore di Sanità (Rome, Italy). The DNA extracted from isolates and strains was quantified using a Qubit fluorometer (Life Technologies, Carlsbad, USA). Human and canine DNA from uninfected donors, purified using the DNeasy Blood & Tissue kit (Qiagen, Valencia, USA), as well as DNA from Trypanosoma cruzi were used as negative controls.

qPCR assays
An 111 bp KDNA region was amplified by a qPCR assay using primers MLF and MLR (referred as qPCR-ML from hereon) as previously described [13]. Briefly, PCR reactions were carried out in 25 μl volume with 1 μl template DNA (corresponding to 0.1-1 ng parasite DNA) and 24 μl SYBR green PCR master mix (Diatheva srl, Fano, Italy) containing 1 U Taq Polymerase and 200 nM of each primer in a Rotor-Gene 6000 instrument (Corbett Life Science, Mortlake, Australia). The amplification conditions were: 94°C for 10 min, 40 cycles at 94°C for 30 s, 60°C for 20 s and 72°C for 20 s. At the end of each run, a melting curve analysis was performed from 78 to 92°C, with a slope of 1°C/s, and 5 s at each temperature. The reactions were performed in duplicate or triplicate.
To amplify L. (L.) amazonensis DNA minicircles, a new qPCR assay (referred as qPCR-ama from hereon) was designed using the forward primer LMi-amaF (5′-AAA ATG AGT GCA GAA ACC C-3′) with the reverse primer MLR. The LMi-amaF primer was designed specifically for this work exploiting two mismatches (G/A and T/C) among L. (L.) infantum and L. (L.) amazonensis sequences (Fig. 1). The LMi-amaF sequence was tested with BLAST against the non-redundant nucleotide database (organism limited to Leishmania). The position of all primers in the qPCR-ML amplicons is shown in Fig. 1. The qPCR-ama was performed at the same ) amazonensis isolate is boxed. *Sequence of non-digested products after EcoRI restriction conditions described above. A standard curve for qPCRama was established using L. (L.) amazonensis MHOM/ BR/00/LTB0016 DNA serial dilutions, ranging from 1.0 to 1 × 10 -4 ng. The standard curve concentration was expressed as ng/μl. To evaluate the potential interference of host DNA as background in the qPCR analysis, 30 ng of human DNA were spiked in the reaction tubes. The cycle threshold (C q ) values were determined using the quantitation analysis of the Rotor-Gene 6000 software, setting a threshold to 0.15.

High-resolution melt (HRM) analysis
The qPCR-ML amplicons, obtained by all stains/isolates listed in Table 1 and by 62 samples from 21 dogs affected by leishmaniasis, were analysed in duplicate by HRM protocol on a Rotor-Gene 6000 instrument as described previously [13] with slight modifications. Briefly, HRM was carried out over the range from 78°C to 92°C, rising at 0.1°C/s and waiting for 2 s at each temperature. Each sample was run in duplicate or triplicate, and the gain was optimised before melting on all tubes. HRM curve analysis was performed with the derivative of the raw data, after smoothing, with the Rotor-Gene 6000 software. Only samples with C q values ˂ 30 were considered for subsequent analysis [13,22].

PCR product sequencing
The qPCR-ML products obtained from the canine clinical samples and the strains/isolates (Table 1, except for IFLA/BR/67/PH8 and MHOM/BR/75/M2904 strains), were purified using the MinElute PCR purification kit (Qiagen) and directly sequenced using both MLF and MLR primers. DNA sequencing was performed using the BigDye Terminator v. 1.1 Cycle Sequencing Kit on ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, USA). Sequences were manually edited and aligned using default options in MUSCLE [23]. Phylogenetic and nucleotide composition analyses were conducted using MEGA version 6 [24].

RFLP analysis
The RFLP analysis was performed on qPCR-ML products with EcoRI restriction enzyme (Roche Life Sciences, Indianapolis, USA), following the manufacturer's protocol. The EcoRI digestion was performed at 37°C for 2 h in a 20 μl mixture containing 7 U of enzyme and 50-100 ng of PCR products. The digestion mixtures were analysed on a 3% high-resolution MetaPhor (Cambrex, East Rutherford, USA) agarose gel, and the selected products were excised, purified with MinElute PCR purification kit (Qiagen) and sequenced as described above.

Statistical analysis
Statistical analysis was performed with GraphPad InStat version 3.06 (GraphPad Software, San Diego, CA).
Differences among T m values were evaluated using an Unpaired t-test with Welch's correction. Normality distribution was assessed by D' Agostino & Pearson omnibus normality test (alpha = 0.05).
A restriction site for EcoRI was evidenced in the L. (L.) amazonensis isolate, but it was not confirmed in L. (L.) amazonensis MHOM/BR/00/LTB0016 strain (Fig. 1), making it not feasible to develop a PCR-RFLP assay to distinguish L. (L.) amazonensis from L. (L.) infantum. Moreover, Fig. 2 Maximum likelihood phylogenetic tree of qPCR-ML amplicons. The tree was constructed with MEGA 6 software using Tamura-Nei model. *Sequence of non-digested product after EcoRI restriction the RFLP analysis of the L. (L.) amazonensis isolate revealed a partial digestion of the PCR product (Additional file 1: Figure S1). The non-cleaved band was extracted from the gel and directly sequenced. The lack of a EcoRI restriction site, as well as many similarities with the L. (L.) infantum sequences (Figs. 1 and 2), showed the presence of different minicircle classes amplified by the qPCR-ML assay. Previously, we demonstrated that HRM analysis of qPCR-ML products can discriminate between the Leishmania subgenera Leishmania and Viannia, and can differentiate the L. (L.) infantum MHOM/TN/80/IPT1 reference strain (two melting peaks) from L. (L.) amazonensis (one melting peak) [13]. However, HRM analysis performed on several clinical specimens from dogs infected by L. (L.) infantum, showed two peaks comparable to L. (L.) infantum MHOM/ TN/80/IPT1 or a profile with a single melting peak, suggesting a kDNA minicircle parasite variability [13]. To confirm and further extend these data, we performed HRM analysis on qPCR-ML products obtained by amplification of L. (L.) infantum strains/isolates listed in Table 1 and 62 canine clinical samples from 21 dogs infected by L. (L.) infantum. The results showed that 22% and 56% of the L. (L.) infantum amplicons presented a double melting peak and a single melting peak, respectively. The remaining 22% of samples was undetermined due to lack of reproducibility between replicates. L. (L.) amazonensis amplicons always had a single melting peak. T m values between L. (L.) amazonensis isolate, and MHOM/BR/00/LTB0016 strain was not significantly different (unpaired t-test with Welch's correction, t = 1.23, P = 0.246). T m values of strain IFLA/ BR/67/PH8 were not considered due to late amplification (C q ˃ 30) and consequent lack of reproducible T m profiles [22]. The mean T m of L. (L.) amazonensis amplicons was significantly different from the mean T m of L. (L.) infantum amplicons showing a single peak (unpaired t-test with Welch's correction, t = 8.77, P ˂ 0.001) ( Table 2). However, the T m value distribution overlapped (Fig. 3), therefore  The efficiency and detection limit of the qPCR-ama assay were evaluated using 10-fold serial dilutions of L. (L.) amazonensis MHOM/BR/00/LTB0016 DNA (from 1.0 to 1 × 10 -4 ng) in 2 independent experiments in duplicate or triplicate. There was a linear correlation between the log of DNA concentration and C q value (slope =-3.39, R 2 = 0.98) with a reaction efficiency of 97% (Fig. 4). To verify the interference of host DNA, the standard curve was also spiked with 30 ng of purified human DNA. The presence of host DNA delayed the C q values in the standard curve, while the assay efficiency remained similar (Fig. 4). The detection limit was 0.1 pg of parasite DNA in the spiked samples, corresponding roughly to 1.3 parasites/PCR tube.    [25], adding 9.7 fg (15%) kDNA [26]. The calculated total DNA for a single parasite was 74.5 fg.
The specificity of the primers was first tested using two strains and one isolate of L. (L.) amazonensis, Trypanosoma cruzi and host DNA (human or canine). No amplification was observed when using T. cruzi, human or canine DNA, while all L. (L.) amazonensis strains were positive on qPCR (Fig. 5). C q values were much lower compared to C q obtained with qPCR-ML using the same template amount ( Table 3). The qPCR-ama was then tested with strains of L. infantum isolates/strains did amplify, but C q values were dramatically increased compared to qPCR-ML. If template DNA was diluted to have C q ˃ 25 in qPCR-ML, there was no detectable amplification from qPCR-ama (Table 3). As evidence of this, the canine clinical samples tested with qPCR-ML (with C q ˃ 25) had negative results with qPCR-ama, confirming infection by L. (L.) infantum (Table 4). Combined evaluation of qPCR-ML and qPCR-ama C q values provided discrimination between L. (L.) infantum and L. (L.) amazonensis in all tested samples.

Discussion
Previous work has shown that the Leishmania (Leishmania) and Leishmania (Viannia) subgenera could be distinguished by exploiting kDNA variability through HRM analysis of qPCR-ML amplicons [13]. Here, several qPCR-ML amplicons from different Leishmania species were sequenced, indicating the presence of different subclasses of minicircles amplified from the same species. Notably, the presence of over 100 minicircles classes encoding different gRNAs in a strain of L. tarentolae has been reported and quantified using NGS technology, indicating the heterogeneity of the mitochondrial genomes in this parasite [27]. The EcoRI partial digestion of the amplicon obtained from L. (L.) amazonensis isolate confirmed the presence of different sequences in the same PCR product. In fact, the sequence of the non-digested product evidenced a subclass of molecules without the EcoRI site, clustering with L. (L.) infantum sequences. The fact that the sequence of this product was not visible in the first sequence analysis can be explained by a relatively low presence of this minicircle subclass.
Leishmania (L.) infantum and L. (L.) amazonensis infect both humans and dogs, and they can coexist in the same geographical area; therefore, their differentiation is critical for correct treatment. Notably, Sanches et al. [28] showed a high percentage of L. (L.) amazonesis infection in naturally infected dogs in an endemic area, underlining the necessity to discriminate these two species not only in human but also in veterinary medicine.

Table 3 qPCR-ML and qPCR-ama results
Since HRM analysis resulted inconclusive for discrimination of L. (L.) infantum and L. (L.) amazonensis in about 53% of samples, a new SYBR-green qPCR assay (qPCRama) was designed to amplify a minicircle subclass preponderant in L. (L.) amazonensis, rather than targeting a hypothetical species-specific sequence. In fact, several PCR assays designed on minicircles also reported amplification of non-intended species [17,29]. Moreover, Gomes et al. [30] showed that non-target organisms such as T. cruzi could be amplified, even if C q values are ˃ 30. Therefore, the performance of different qPCR assays in series or the standardisation of multiplex qPCR appeared to be the only way of properly identifying different Leishmania species [31]. Due to the difficulties in designing species-specific primers, we based our qPCR assay on the evaluation of relative abundance of minicircle subclasses. We observed that qPCR-ML amplified several Leishmania species including L. (L.) amazonensis but to a much less sensitivity (higher C q ). The opposite was found for qPCR-ama: in this case, L. (L.) amazonensis was amplified much more efficiently (lower C q ) compared to the other tested species, because primers were designed on a minicircle sequence that was more abundant in this species. Therefore, we have been focusing on C q rather than presence or absence of an amplification curve. Hence, a minicircle subclass most represented in L. (L.) amazonensis was used as a target to differentiate L. (L.) amazonensis and L. (L.) infantum. The template DNA can be diluted to make undetectable the low-represented minicircle subclasses. The data in Table 3 show clearly this point: if DNA template from L. (L.) infantum was diluted to have C q ˃ 25 in qPCR-ML (considering 1:10 dilution equivalent to~3.3 cycles increase), the qPCRama turned negative. On the contrary, under appropriate dilution conditions, the qPCR-ama will give positive amplification only for L. (L.) amazonensis species (Table 3). These conditions could also be met by clinical samples, in which pathogen DNA is low represented respect to host DNA and the C q can be delayed (as evidenced in the qPCR-ama standard curves).
The results of in silico analysis accounted for the possibility to amplify more L. (L.) amazonensis strains other those tested in this work, despite the database does not give information about the relative abundance of the kDNA minicircle sequences into the different strains. For example, the kDNA minicircle sequence of strain IFLA/BR/67/PH8 (GenBank M21325) shows a mismatch in the LMi-amaF sequence (Additional file 2: Figure S2) but it was efficiently amplified in our assay (Table 3), probably due to the presence of another minicircle subclass matching the primer sequence.
Taken together, a new diagnostic approach for Leishmania species discrimination from clinical samples or isolates has been developed: first, a qPCR-ML followed by HRM analysis is performed. In the case of lack of amplification, or if HRM results are inconclusive, the qPCR-ama assay is performed, and the evaluation of C q values for both assays will allow the discrimination of the two Fig. 6 A possible diagnostic approach based on qPCR and HRM analysis. The qPCR-ML followed by HRM analysis is performed. In the case of lack of amplification, or if HRM results are inconclusive, the qPCR-ama can also be performed. The evaluation of C q values for both assays will allow discriminating between L. (L.) infantum and L. (L.) amazonensis  (Fig. 6). This approach is affordable for any molecular diagnostic laboratory equipped with an HRM qPCR instrument since it is based on an SYBR green chemistry and requires only three primers. Moreover, since the cost per reaction is relatively low (less than 1 €) and the PCR conditions are the same, the two assays could be run simultaneously to speed up the diagnostic process.